Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Sales of Investments

Cash received from selling or redeeming investments.

Strata Critical Medical, Inc.NASDAQ: SRTA

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments dips below year-ago levels

Q1 FY2026 sales of investments of $30.5M fell 71.7% year over year, behind the +20.1% change in trailing-twelve-month sales of investments. Sequentially, it rose 31.5% from the prior quarter. Over 3 fiscal years it compounded at -6.0% a year.

Context

  • Sales of investments amounted to 150.3% of revenue in FY2025, up 79.0 pp from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -71.7% toward the trailing-twelve-month pace of +20.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$30.5M+31.5% QoQ
Last fiscal yearDec 2025
$296.36M+67.0% YoY
LTMMar 2026
$219.11M+20.1% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-71.7%——
1 year+67.0%——
3-year CAGR-6.0%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
296.36M USD
Year-over-year change
+67.0%
4-year CAGR
+126.3%

Sales of Investments vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +20.1% is the 2nd highest of 6, against a peer median of -67.0%.
  • Sales of investments amounts to 86.2% of revenue for SRTA, versus a peer median of 0.9%.
SRTA Competitors
Sales of Investments for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZIPZipRecruiter, Inc.LTM Mar 2026$550.89M USD-12.5%+182.7%123.4%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$219.11M USD+20.1%-6.0%86.2%
CYRXCryoport, Inc.LTM Mar 2026$78.59M USD-67.0%-23.3%43.0%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$13.48M USD+8487.9%—0.9%
FLYXflyExclusive, Inc.LTM Mar 2026$11.58M USD-89.8%+98.4%3.0%
EBFEnnis, Inc.LTM Feb 2026$5.5M USD-84.3%—1.4%
KFRCKforce Inc.LTM Mar 2026$0 USD——0.0%
ORNOrion Group Holdings, Inc.LTM Mar 2026$0 USD——0.0%
MTRXMatrix Service CompanyLTM Mar 2026$0 USD——0.0%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$0 USD——0.0%
EVTLVertical Aerospace Ltd.LTM Mar 2026£0 GBP———
Peer median (excluding SRTA) —-67.0%+98.4%0.9%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.